I first heard of SGX Pharma when they were mentioned over on Silicon Investor as having a highly specific C-Met compound that was still unpartnered. Sounded interesting, but there doesn't seem to be much written about the company. I did get to listen to a presentation they had back in May though (JP Morgan Conf).
It looks like after their Troxatyl program bombed out last year, interest in the company waned. The stock steadily recovered though, and had a recent spike that corresponded to the term sheet rumor, so perhaps there's something to it. The way BPs are throwing money at early stage programs these days, I figure SGX could be an easy double if the term sheet rumor turns out to be true. I started nibbling but then unloaded to sidestep the recent market downturn. I'm back in Cortex now, so there isn't much available for other stocks at the moment unfortunately.
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM